This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for COMIRNATY® Omicron XBB.1.5▼ (raxtozinameran) COVID-19 mRNA Vaccine (nucleoside modified), COMIRNATY® Original/Omicron BA.4-5▼ (tozinameran / famtozinameran) COVID-19 mRNA Vaccine (nucleoside modified), COMIRNATY® Original/Omicron BA.1▼ (tozinameran / riltozinameran) COVID-19 mRNA Vaccine (nucleoside modified) and COMIRNATY®▼ (tozinameran) COVID-19 mRNA Vaccine (nucleoside modified) Great Britain (GB) and Northern Ireland (NI)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB

    COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, children 5 to 11 years - PI for GB

    COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 6 months to 4 years - PI for GB

    COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB
  • COMIRNATY Original/Omicron BA.1 (tozinameran / riltozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB
  • COMIRNATY (tozinameran) 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 12+ years - PI for GB
  • COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, children 5 to 11 years - PI for GB
  • COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified), dilute before use, 6 months to 4 years -  PI for GB 

Northern Ireland

  • COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for NI

    COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, children 5 to 11 years - PI for NI

    COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 6 months to 4 years - PI for NI

    COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12 + years - PI for NI 
  • COMIRNATY Original/Omicron BA.1 (tozinameran / riltozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for NI
  • COMIRNATY (tozinameran) 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 12+ years - PI for NI
  • COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, children 5 to 11 years - PI for NI
  • COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified), dilute before use, 6 months to 4 years - PI – NI

COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB

COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, children 5 to 11 years - PI for GB

COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 6 months to 4 years - PI for GB

COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for NI

COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) ready for use, children 5 to 11 years - PI for NI

COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 6 months to 4 years - PI for NI

COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB


COMIRNATY Original/Omicron BA.1 (tozinameran / riltozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for GB


COMIRNATY (tozinameran) 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 12+ years - PI for GB

COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, children 5 to 11 years - PI for GB

COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified), dilute before use, 6 months to 4 years -  PI for GB 


COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12 + years - PI for NI 


COMIRNATY Original/Omicron BA.1 (tozinameran / riltozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ready for use, 12+ years - PI for NI



COMIRNATY (tozinameran) 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, 12+ years - PI for NI

COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) dilute before use, children 5 to 11 years - PI for NI

COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified), dilute before use, 6 months to 4 years - PI – NI

PP-CMR-GBR-0423 September 2023